LIC MF Healthcare Fund Direct Growth

LIC MF Healthcare Fund Direct Growth

Equity

LIC Mutual Fund

Sector - Healthcare

Get the latest NAV of LIC MF Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹31.55

▲0.5%1D

NAV as on 01 Jul 2025

19.97%/per year

Since Inception

Absolute Gain%

▲▼

110 people have invested ₹ 3.4L in LIC MF Healthcare Fund Direct Growth in the last three months

LIC MF Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (01-Jul-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.

Period
This Fund
Nifty 500
Category Avg
1 Month
3.36%
3.57%
3.49%
3 Months
3.05%
12.08%
6.21%
6 Months
-4.03%
5.04%
-2.97%
1 Year
19.01%
3.91%
17.9%
3 Years
23.24%
20.81%
25.28%
5 Years
19.03%
22.52%
22.09%

INDmoney Rank

Powered by IND quant engine

IND ranking is not available for this fund.

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
LIC MF Healthcare Fund
-
84Cr
1.22%
19.01%
23.24%
19.97%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,689Cr
0.9%
22.24%
30.71%
18.37%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,689Cr
0.9%
22.24%
30.71%
18.37%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
2/8
5,508Cr
1.06%
23.35%
31.07%
23.05%
See all
Positive: Beats FD returns for both 3Y & 5Y duration
Beats FD returns for both 3Y & 5Y duration
Negative: 5Y returns in the bottom 25% of the category
5Y returns in the bottom 25% of the category
Negative: 3Y returns in the bottom 25% of the category
3Y returns in the bottom 25% of the category

LIC MF Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

LIC MF Healthcare Fund Asset Allocation

See fund asset allocation details as on (14-Jun-25)

Fund Distribution

as on (14-Jun-25)

Equity 96.6%

Debt & Cash 3.4%

Mid cap
33.6%
Small cap
31.3%
Large cap
27.6%
Small Cap allocation has gone down from 33.4% to 31.3%
Small Cap allocation has gone down from 33.4% to 31.3%
Mid Cap allocation has gone up from 30.7% to 33.6%
Mid Cap allocation has gone up from 30.7% to 33.6%
Large Cap allocation has gone up from 26.3% to 27.6%
Large Cap allocation has gone up from 26.3% to 27.6%
Cash allocation has gone down from 4.2% to 3.4%
Cash allocation has gone down from 4.2% to 3.4%

LIC MF Healthcare Fund Sector Allocation

See fund sector allocation details as on (14-Jun-25)

Sector Allocation

Equity 96.6%

Debt & Cash 3.4%

Health
96.7%
Basic Materials
3.3%

Top 2 Sectors in May were Health, Basic Materials

May'25

Health

91%

Basic Materials

9%

Apr'25

Health

93%

Basic Materials

7%

LIC MF Healthcare Fund Holdings Details

as on (30-Jun-25)

Equity

Top Stocks bought last month
Fortis Healthcare Ltd's allocation increased from 2.13% to 4%
Fortis Healthcare Ltd's allocation increased from 2.13% to 4%
Neuland Laboratories Ltd's allocation increased from 3.11% to 4.11%
Neuland Laboratories Ltd's allocation increased from 3.11% to 4.11%
Sun Pharmaceuticals Industries Ltd's allocation increased from 10.09% to 10.73%
Sun Pharmaceuticals Industries Ltd's allocation increased from 10.09% to 10.73%
Top Stocks sold last month
Torrent Pharmaceuticals Ltd's allocation decreased from 5.18 % to 4.95 %
Torrent Pharmaceuticals Ltd's allocation decreased from 5.18 % to 4.95 %
Aurobindo Pharma Ltd's allocation decreased from 4.57 % to 4.27 %
Aurobindo Pharma Ltd's allocation decreased from 4.57 % to 4.27 %
Piramal Pharma Ltd's allocation decreased from 5.27 % to 4.22 %
Piramal Pharma Ltd's allocation decreased from 5.27 % to 4.22 %

LIC MF Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio1.22%
Benchmark
BSE Healthcare TR INR
AUM₹84 Cr
Inception Date28 February, 2019
Min Lumpsum/SIP₹5000/₹200
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
414.8%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About LIC MF Healthcare Fund

LIC MF Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 February, 2019. The fund is managed by Karan Doshi. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. LIC MF Healthcare Fund Direct Growth has ₹84 Cr worth of assets under management (AUM) as on Jun 2025 and is more than category average.
  2. The fund has an expense ratio 1.2.

Returns

LIC MF Healthcare Fund Direct Growth has given a CAGR return of 19.97% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 19.01%, 23.24% and 19.03% respectively.

Holdings

LIC MF Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Divi's Laboratories Ltd, Aurobindo Pharma Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of LIC MF Healthcare Fund Direct Growth

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 200.00. LIC MF Healthcare Fund Direct Growth has no lock in period.

Fund Manager

Karan Doshi

Fund Manager of LIC MF Healthcare Fund Direct Growth, since 31 July 2023

Learn more about LIC Mutual Fund
Parameters
May'25
Apr'25
Mar'25
AUM
₹ 84.2 Cr
₹ 84.2 Cr
₹ 82.7 Cr
  • AUM of the fund stands at 84.2 Cr as of May'25
  • AUM has remained same between May'25 and Apr'25

Compare LIC MF Healthcare Fund

LIC MF Healthcare Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for LIC MF Healthcare Fund Direct Growth

How do I invest in LIC MF Healthcare Fund?

INDmoney makes it simple to invest in the LIC MF Healthcare Fund. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘LIC MF Healthcare Fund’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of LIC MF Healthcare Fund?

The NAV of the fund today is ₹31.55. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

LIC MF Healthcare Fund fund has generated a return of 19.01% in 1 year, 23.24% in 3 years, 19.03% in 5 years.

Who is the fund manager of LIC MF Healthcare Fund?

The fund managers are Karan Doshi.

What is the exit load of the fund?

The exit load is 1% if redeemed in 0-90 Days. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 1.22%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹84 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of LIC MF Healthcare Fund?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(10.73%), Cipla Ltd(5.43%), Torrent Pharmaceuticals Ltd(4.95%)